Advertisement

Migraine

Inability to Avoid Migraine Pain Causes Helplessness

Jul 05, 2022

Evidence indicates that pain avoidance behaviors are often heightened after recent pain events and can be disrupted when people experience uncontrollable stress. “This disruption can lead to malad...

Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-state fMRI study.

Sep 13, 2021

Medication-overuse headache (MOH) is a relatively frequently occurring secondary headache caused by overuse of analgesics and/or acute migraine medications. It is believed that MOH is associated with ...

Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey.

Sep 13, 2021

Migraine is a primary headache disorder characterized by recurrent attacks that may have a significant impact on patients' daily life. Treatment options must often be re-evaluated in light of efficacy...

Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users.

Sep 13, 2021

The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine...

Lost diagnoses in not otherwise specified headache in Emergency Department.

Aug 30, 2021

 The diagnosis of Not Otherwise Specified (NOS) headaches in the Emergency Department (ED) is frequent despite many specialist visits performed. The aim of the study was to examine specialist visits ...

Current Perspective on Retinal Migraine.

Aug 30, 2021

Retinal migraine was first formally described in 1882. Various terms such as "ocular migraine" and "ophthalmic migraine" have since been used interchangeably in the literature. The lack of a consisten...

Periorbital Nociception in a Progressive Multiple Sclerosis Mouse Model Is Dependent on TRPA1 Channel Activation.

Aug 30, 2021

Headaches are frequently described in progressive multiple sclerosis (PMS) patients, but their mechanism remains unknown. Transient receptor potential ankyrin 1 (TRPA1) was involved in neuropathic noc...

Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice.

Aug 19, 2021

Erenumab is a monoclonal antibody, targeted against the calcitonin gene-related peptide (CGRP) receptor. Clinical studies have demonstrated prophylactic efficacy in both episodic (EM) and chronic migr...

Atogepant for the Preventive Treatment of Migraine.

Aug 19, 2021

Atogepant is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist that is being investigated for the preventive treatment of migraine.In a phase 3, double-blind trial, we rando...

Tinnitus & Subjective Hearing Loss More Common in Migraine

Aug 17, 2021

“Tinnitus is a condition that affects approximately 10% of the adult population in the United States and can diminish one’s quality of life,” explains Hamid R. Djalilian, MD. “To date, there a...

Sensory Hypersensitivities in Migraine Significantly Impact Disability

Aug 08, 2021

“Migraine, which affects more than 1 billion people worldwide, is one of the leading causes of disability in people younger than 50,” says Keisuke Suzuki, MD, PhD. “In addition to moderate-to-se...

Standardized Headache Therapy in the Pediatric Emergency Department Using Improvement Methodology.

Aug 05, 2021

Primary headache is a common cause of pediatric emergency department (PED) visits. Without published guidelines to direct treatment options, various strategies lacking evidence are often employed. Thi...

Oral cannabinoid preparations for the treatment of chronic migraine: a retrospective study.

Aug 05, 2021

To explore the effectiveness and safety of 3 oral cannabinoid preparations (FM2®, Bedrocan® and Bediol®) in the treatment of chronic migraine.Retrospective, cohort study.Patients with chronic migra...

Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary.

Jun 24, 2021

Lockdown measures due to the COVID-19 pandemic have led to lifestyle changes, which in turn may have an impact on the course of headache disorders. We aimed to assess changes in primary headache chara...

Is psychiatric morbidity in chronic migraine associated with poor outcome: Experience from a tertiary care centrer.

Jun 24, 2021

Chronic Migraine is defined as headache occurring on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of migraine headache. This constitutes 10%-15% of a...

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.

Jun 24, 2021

To incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults.The American Headache...

Internet addiction, headache, and insomnia in university students: a cross-sectional study.

Jun 10, 2021

There is controversy about whether there is an association between headache and internet addiction. Therefore, the objective was to assess whether there is an association between the headache, insomni...

Validity and reliability of the self-administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: A prospective clinic-based study.

Jun 10, 2021

To assess the validity and reliability of the self-administered Visual Aura Rating Scale (VARS) questionnaire using a hospital-based sample in a cross-sectional setting.Visual aura is the most common ...

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine.

Jun 03, 2021

Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. We used transcranial magnetic stimulation (TMS) to evaluate changes in cortical excitability and pla...

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.

Jun 03, 2021

The pseudotumor cerebri syndrome embraces disorders characterised by raised intracranial pressure, where the commonest symptom is headache (90%). Idiopathic intracranial hypertension without papilloed...